Artificial intelligence specialist Owkin has added another piece to its medical research portfolio with the launch of ATLANTIS, a patient data mining programme, in partnership with 20 leading ...

Today, most drug discovery programmes begin with the identification and validation of disease modifying biological targets. The primary way to uncover these targets is through searching and reviewing ...